Evonik has revealed details of a €3bn investment to the business that looks to ‘realign’ its portfolio management, innovation and corporate culture by 2030.
Chemicals company Evonik, announces the development of a collagen form made using fermentation-based processes that do not use animal or human-derived materials.
Phytochemical firm Evonik Industries is to acquire Wilshire Technologies in a move to beef up its Care Solutions business line with a nutricosmetics component.